Cargando…
Using microarray‐based subtyping methods for breast cancer in the era of high‐throughput RNA sequencing
Breast cancer is a highly heterogeneous disease that can be classified into multiple subtypes based on the tumor transcriptome. Most of the subtyping schemes used in clinics today are derived from analyses of microarray data from thousands of different tumors together with clinical data for the pati...
Autores principales: | Pedersen, Christina Bligaard, Nielsen, Finn Cilius, Rossing, Maria, Olsen, Lars Rønn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275246/ https://www.ncbi.nlm.nih.gov/pubmed/30289602 http://dx.doi.org/10.1002/1878-0261.12389 |
Ejemplares similares
-
Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status
por: Rossing, Maria, et al.
Publicado: (2021) -
Whole genome sequencing of breast cancer
por: Rossing, Maria, et al.
Publicado: (2019) -
A Comparison of Tools for Copy-Number Variation Detection in Germline Whole Exome and Whole Genome Sequencing Data
por: Gabrielaite, Migle, et al.
Publicado: (2021) -
MicroRNA Changes in Cerebrospinal Fluid After Subarachnoid Hemorrhage
por: Bache, Søren, et al.
Publicado: (2017) -
Amplicon-Based NGS Panels for Actionable Cancer Target Identification in Follicular Cell-Derived Thyroid Neoplasia
por: Madsen, Majbritt Busk, et al.
Publicado: (2020)